Corestate Capital (CCAP) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
17 Jun, 2025Executive summary
Strategic realignment continues, focusing on divesting non-core assets and supporting Hannover Leasing's growth.
Announced sale of STAM Europe SAS to Atland Group, expected to close by Q2 2025.
Transitioned to a pure holding structure; leadership changes fully implemented.
Financial highlights
Aggregated revenue and gains for Q1 2025 were €8.7m, up from €7.8m in Q1 2024.
EBITDA for Q1 2025 was €2.2m, down from €7.1m in Q1 2024.
Net profit for Q1 2025 was €8.8m, compared to €14.5m in Q1 2024; adjusted net profit was €7.9m vs. €12.6m.
Cash and cash equivalents at March 31, 2025, were €21.4m; net debt increased to €200.8m.
Assets under management at period end were €8.5bn, down from €8.7bn at year-end 2024.
Outlook and guidance
Plans to realize asset sales of approx. €12.7m by June 2025 to pay €7.5m interest for H1 2025.
Additional asset sales of up to €72.0m targeted by year-end to repay Super Senior Note and begin repayments of Reinstated Senior Notes.
Latest events from Corestate Capital
- Significant losses and deleveraging mark a challenging transition to a holding structure.CCAP
Q3 20255 Jan 2026 - Revenue and EBITDA fell, but asset sales and liquidity support ongoing deleveraging.CCAP
Q2 20255 Sep 2025 - Restructuring nearly complete; focus shifts to asset sales and deleveraging amid market headwinds.CCAP
Q4 20248 Aug 2025 - Net loss, lower equity, and delayed asset sales mark Corestate's ongoing restructuring.CCAP
Q3 202413 Jun 2025 - EBITDA loss narrowed and asset sales accelerated, but AUM and equity ratio declined.CCAP
Q2 202413 Jun 2025 - Losses narrowed and asset sales progressed, but liquidity remains a key challenge.CCAP
Q1 202413 Jun 2025